UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Growth hormone effects on cortical bone dimensions in young adults with childhood-onset growth hormone deficiency

Osteoporosis international, 2012-08, Vol.23 (8), p.2219-2226

2012

Volltextzugriff (PDF)

The efficacy and safety of long-term Norditropin® treatment in children with Prader-Willi syndrome

Hormone and metabolic research, 2013-07, Vol.45 (7), p.532-536

2013

Volltextzugriff (PDF)

PO2-22: Usability and safety of FlexPro® PenMate®, a growth hormone (GH) injection system, in patients, caregivers and healthcare professionals

Growth hormone & IGF research, 2014-10, Vol.24, p.S46-S46

2014

Volltextzugriff (PDF)

PO2-7: Assessing the impact of storage flexibility on daily life for patients and caregivers taking/administering growth hormone (GH)

Growth hormone & IGF research, 2014-10, Vol.24, p.S41-S41

2014

Volltextzugriff (PDF)

PO2-2: An evaluation of the safety and usability of FlexPro® 30 mg/3 mL, for the delivery of Norditropin® in patients requiring growth hormone (GH) therapy

Growth hormone & IGF research, 2014-10, Vol.24, p.S39-S39

2014

Volltextzugriff (PDF)

P03-40 Comparison of intuitiveness, ease of use and preference in five growth hormone injection devices

Growth hormone & IGF research, 2012-10, Vol.22, p.S86-S86

2012

Volltextzugriff (PDF)

P03-34 Dose-dependent response of Δ insulin-like growth factor I and Δ height to long-term growth hormone therapy in short Japanese children born small for gestational age

Growth hormone & IGF research, 2012-10, Vol.22, p.S83-S84

2012

Volltextzugriff (PDF)

Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency

The journal of clinical endocrinology and metabolism, 1998-02, Vol.83 (2), p.379-381

1998

Volltextzugriff (PDF)

REMOVED: P02-51 Product wastage from modern human growth hormone administration devices: A laboratory analysis

Growth hormone & IGF research, 2012-10, Vol.22, p.S68-S69

2012

Volltextzugriff (PDF)

P01-37 Dose sparing effect of an IGF-I-based dosing regimen in short children treated with Growth Hormone in a 2-Year randomized controlled trial: Therapeutic and pharmacoeconomic considerations

Growth hormone & IGF research, 2012-10, Vol.22, p.S45-S45

2012

Volltextzugriff (PDF)

OR11,63 Growth hormone treatment has a positive effect on spine bone mineral density in young adults with childhood-onset growth hormone deficiency: a meta-analysis

Growth hormone & IGF research, 2010, Vol.20, p.S29-S29

2010

Volltextzugriff (PDF)

P13 Patient Perception of injection pain and anxiety: a comparison of two pen injection device systems, Norditropin® FlexPro® with FlexPro® PenMate®, and Norditropin NordiFlex® with NordiFlex PenMate

Growth hormone & IGF research, 2010, Vol.20, p.S44-S44

2010

Volltextzugriff (PDF)

Long-term effects of continuous subcutaneous infusion versus daily subcutaneous injections of growth hormone (GH) on the insulin-like growth factor system, insulin sensitivity, body composition, and bone and lipoprotein metabolism in GH-deficient adults

The journal of clinical endocrinology and metabolism, 2001-03, Vol.86 (3), p.1222-1228

2001

Volltextzugriff (PDF)

Growth hormone secretagogues: recent advances and applications

Drug Discovery Today, 1999-11, Vol.4 (11), p.497-506

1999

Volltextzugriff (PDF)

P11 Comparison of intuitiveness, ease of use and preference in three growth hormone injection devices

Growth hormone & IGF research, 2010, Vol.20, p.S42-S43

2010

Volltextzugriff (PDF)

OR11,64 Growth hormone (GH) induces a dose-dependent, long-term increase in growth in pre-pubertal children with GH deficiency (GHD) without modifying the rate of initiation of puberty

Growth hormone & IGF research, 2010, Vol.20, p.S29-S30

2010

Volltextzugriff (PDF)

P12 Norditropin increases lean muscle, reduces fat mass and normalizes height in children with Prader-Willi Syndrome

Growth hormone & IGF research, 2010, Vol.20, p.S43-S43

2010

Volltextzugriff (PDF)

OR3,4 Differential dose related GH- and IGF-insensitivity in children with idiopathic short stature and low serum IGF-I: comparison with growth hormone-deficient patients

Growth hormone & IGF research, 2008, Vol.18, p.S7-S8

2008

Volltextzugriff (PDF)

P-23 Bone mineral density and alkaline phosphatase in growth hormone-treated GH-deficient young adults

Growth hormone & IGF research, 2008, Vol.18, p.S33-S34

2008

Volltextzugriff (PDF)

Characterization of growth hormone-releasing hormone stimulation of the endocrine pancreas: studies with alpha- and beta-adrenergic and cholinergic antagonists

Acta endocrinologica (Copenhagen), 1987-04, Vol.114 (4), p.589-594

1987

Volltextzugriff (PDF)

Consensus Guidelines for the Diagnosis and Treatment of Growth Hormone (GH) Deficiency in Childhood and Adolescence: Summary Statement of the GH Research Society

The journal of clinical endocrinology and metabolism, 2000-11, Vol.85 (11), p.3990-3993

Society, G. R.

2000

Volltextzugriff (PDF)

P02-51 Product wastage from modern human growth hormone administration devices: A laboratory analysis

Growth hormone & IGF research, 2012-10, Vol.22, p.S68-S69

2012

Volltextzugriff (PDF)

Synthetic pancreatic growth hormone-releasing factor (GRF-40) stimulates the secretion of the endocrine pancreas

Diabetes (New York, N.Y.), 1986-01, Vol.35 (1), p.119-123

1986

Volltextzugriff (PDF)

Synthetic pancreatic growth hormone-releasing factor (GRF-40) stimulates the secretion of the endocrine pancreas

Diabetes (New York, N.Y.), 1986-01, Vol.35 (1), p.119-123

1986

Volltextzugriff (PDF)

Effects of dose and gender on the growth and growth factor response to GH in GH-deficient children: Implications for efficacy and safety

The journal of clinical endocrinology and metabolism, 2002, Vol.87 (1), p.90-98

2002

Volltextzugriff (PDF)

1 – 25 von 88

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(74)
Mit Volltextzugriff
(59)

Publikationsform

Sprache

Englisch
(86)
Dänisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Growth hormone effects on cortical bone dimensions in young adults with childhood-onset growth hormone deficiency

The efficacy and safety of long-term Norditropin® treatment in children with Prader-Willi syndrome

PO2-22: Usability and safety of FlexPro® PenMate®, a growth hormone (GH) injection system, in patients, caregivers and healthcare professionals

PO2-7: Assessing the impact of storage flexibility on daily life for patients and caregivers taking/administering growth hormone (GH)

PO2-2: An evaluation of the safety and usability of FlexPro® 30 mg/3 mL, for the delivery of Norditropin® in patients requiring growth hormone (GH) therapy

P03-40 Comparison of intuitiveness, ease of use and preference in five growth hormone injection devices

P03-34 Dose-dependent response of Δ insulin-like growth factor I and Δ height to long-term growth hormone therapy in short Japanese children born small for gestational age

Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency

REMOVED: P02-51 Product wastage from modern human growth hormone administration devices: A laboratory analysis

P01-37 Dose sparing effect of an IGF-I-based dosing regimen in short children treated with Growth Hormone in a 2-Year randomized controlled trial: Therapeutic and pharmacoeconomic considerations

OR11,63 Growth hormone treatment has a positive effect on spine bone mineral density in young adults with childhood-onset growth hormone deficiency: a meta-analysis

P13 Patient Perception of injection pain and anxiety: a comparison of two pen injection device systems, Norditropin® FlexPro® with FlexPro® PenMate®, and Norditropin NordiFlex® with NordiFlex PenMate

Long-term effects of continuous subcutaneous infusion versus daily subcutaneous injections of growth hormone (GH) on the insulin-like growth factor system, insulin sensitivity, body composition, and bone and lipoprotein metabolism in GH-deficient adults

Growth hormone secretagogues: recent advances and applications

P11 Comparison of intuitiveness, ease of use and preference in three growth hormone injection devices

OR11,64 Growth hormone (GH) induces a dose-dependent, long-term increase in growth in pre-pubertal children with GH deficiency (GHD) without modifying the rate of initiation of puberty

P12 Norditropin increases lean muscle, reduces fat mass and normalizes height in children with Prader-Willi Syndrome

OR3,4 Differential dose related GH- and IGF-insensitivity in children with idiopathic short stature and low serum IGF-I: comparison with growth hormone-deficient patients

P-23 Bone mineral density and alkaline phosphatase in growth hormone-treated GH-deficient young adults

Characterization of growth hormone-releasing hormone stimulation of the endocrine pancreas: studies with alpha- and beta-adrenergic and cholinergic antagonists

Consensus Guidelines for the Diagnosis and Treatment of Growth Hormone (GH) Deficiency in Childhood and Adolescence: Summary Statement of the GH Research Society

P02-51 Product wastage from modern human growth hormone administration devices: A laboratory analysis

Synthetic pancreatic growth hormone-releasing factor (GRF-40) stimulates the secretion of the endocrine pancreas

Synthetic pancreatic growth hormone-releasing factor (GRF-40) stimulates the secretion of the endocrine pancreas

Effects of dose and gender on the growth and growth factor response to GH in GH-deficient children: Implications for efficacy and safety

Suchergebnisse filtern